Showing 1 - 2 results of 2 for search 'Cesar Magro-Checa', query time: 0.01s Refine Results
  1. 1
    Performance of the proposed ACR–EULAR classification criteria for systemic lupus erythematosus (SLE) in a cohort of patients with SLE with neuropsychiatric symptoms

    Performance of the proposed ACR–EULAR classification criteria for systemic lupus erythematosus (SLE) in a cohort of patients with SLE with neuropsychiatric symptoms by Tom W J Huizinga, Maka Gegenava, Hannelore Jacqueline Lucia Beaart, Rory Caitlin Monahan, Elisabeth Brilman, Liesbeth J J Beaart-van de Voorde, Cesar Magro-Checa, Gerda M Steup-Beekman

    Published 2019-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Multicentre, 26-week, open-label phase 2 trial of the JAK inhibitor filgotinib in Behçet’s disease, idiopathic inflammatory myopathies and IgG4-related disease: DRIMID study protocol

    Multicentre, 26-week, open-label phase 2 trial of the JAK inhibitor filgotinib in Behçet’s disease, idiopathic inflammatory myopathies and IgG4-related disease: DRIMID study protoc... by Sander W Tas, Joost Raaphorst, Paco M J Welsing, Jacob M van Laar, Rogier M Thurlings, Robbert J Goekoop, César Magro Checa, Jan A M van Laar, Bettina C Geertsema-Hoeve, Nicolle H Rekers, Erik Present

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: